Social Media Home Twitter Facebook Linked In RSS Feed Podcasts
Careers in Textiles

Register Subscribe Podcasts

BOSTON – Biotechnology company Evolved by Nature, which has developed a library of silk solutions based on natural proteins, has closed a US$120 million Series C financing round, which it’ll use to scale its infrastructure and capacity.  

The company’s versatile Activated Silk technology can be used in yarn production or as a fabric treatment to improve moisture control and odour release, and has found use across various sectors including healthcare and cosmetics. 

“With this investment, we can now make our library of Activated Silk molecules available to global development partners, so, together, we can enhance the performance potential of – essentially – any surface,” said Rebecca Lacouture, the company’s president, COO and co-founder.

Back Issue Archive
Other Publications from MCL News & Media

Interested in advertising?

Simply give us a call

Sales: +44 1977 708488

Or if you prefer email, click on the button below and we'll get back to you asap